Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients

Introduction: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve cardiovascular prognosis in patients with chronic kidney disease (CKD), diabetes, and heart failure; and slow the decline of kidney dysfunction in patients with albuminuria. Although safety and efficacy of SGLT2i have not been...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney International Reports
Main Authors: Lucie Maigret, Lucile Basle, Valérie Chatelet, Laure Ecotiere, Peggy Perrin, Léonard Golbin, Dominique Bertrand, Dany Anglicheau, Coralie Poulain, Cyril Garrouste, Clément Danthu, Charlotte Boud'hors, Yannick Le Meur, Manon Dekeyser, Fabien Duthe, Bénédicte Sautenet, Pierre-Guillaume Deliège, Philippe Gatault
Formato: Artigo
Publicado em: Elsevier 2025-03-01
Assuntos:
Proteinuria
Renal transplantation
Sodium-glucose cotransporters-2 inhibitors
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2468024924020552
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

http://www.sciencedirect.com/science/article/pii/S2468024924020552

Registos relacionados